Home Tags Biotech
GameStop (NYSE: GME) gains 14% in the market after the capital increase completes, selling $ 551 million worth of common stock.
. . The FDA panel acts as the scientific court, pulling out the data and debating whether the shot is safe and effective enough to be cleared for emergency use.
. . Small-cap immunotherapy company Immutep Ltd (ASX: IMM) is absolutely flying today. The Immutep share price is 57% higher. 14% at the time of writing. The company had some fantastic news to share this morning. . .
. . Immutep's Chinese partner (IMM), EOC Pharma, will start a phase II clinical trial in patients with metastatic breast cancer.
. . An earthquake with a magnitude of 6. 7 shook northern parts of Taiwan late Thursday, according to the island's Central Weather Bureau. The quake was centered off Taiwan's northeast coast at a depth of 77 kilometers, the weather bureau said. Buildings in the capital Taipei shook briefly, but there were no immediate reports of injuries or significant damage. (Reporting by Yimou Lee and Ben Blanchard; Editing by Alex Richardson)
. . Global biotechnology company Immutep (ASX: IMM) has announced that its Chinese partner EOC Pharma will start a phase II clinical trial to evaluate the efficacy and safety of the lead drug eftilagimod alpha in the treatment of metastatic breast cancer.
. . Since dec. . 3, Collbran Cafe was the place in the tiny town on Grand Mesa.
. . Closing Bell is Stockhead's daily round-up of the ASX's biggest players - winners and losers alike. The data is collected after the market closes at 4 p.m. AEDT. Stocks highlighted in yellow rose after announcements. WINNERS Scroll or swipe to view the table. Click Headings to sort. Among the stocks with moving announcements, Biotech Immutep (ASX: IMM) held [...]
. . Immunotherapy company Immutep (ASX: IMM) announced what it describes as promising overall survival data from a breast cancer study with its eftilagimod. . .